Tirzepatide approved for weight loss treatment by regulator The Medicines and Healthcare products Regulatory Agency has said tirzepatide will be available to patients with obesity, or who are overweight, with weight-related health problems.…
Medicines regulator approves anastrozole for prevention of breast cancer in post-menopausal women NHS England says around 289,000 women at moderate or high risk of breast cancer could benefit from anastrozole.…
Community pharmacy staff asked for views on provision of PrEP as part of NIHR research project The University of Bristol is conducting research on the barriers community pharmacies must overcome if they are to provide HIV pre-exposure prophylaxis.…
Community pharmacy pilot service to refer patients with cancer symptoms expanded Exclusive: The East of England North Cancer Alliance and South East London Cancer Alliance plan to begin offering the NHS community pharmacy ‘early diagnosis of cancer’ pilot service in 2024.…
Safety measures introduced for isotretinoin prescribing in patients aged under 18 years Recommendations to improve the safety of prescribing the acne drug isotretinoin have been made by the Commission on Human Medicines.…
UK regulator seizes 369 potentially fake weight loss pens following reports of hospitalisations The Medicines and Healthcare products Regulatory Agency said the public should consult a healthcare professional qualified to provide semaglutide and liraglutide via prescription.…
HRT prescribing increased by almost half in one year, NHS figures show Data show that 10.9 million hormone replacement therapy items were prescribed in England in 2022/2023, up from 7.4 million items in 2021/2022.…
UK regulator to consider EMA recommendation to avoid topiramate in pregnancy Exclusive: The UK medicines regulator said it would carefully consider recommendations made by the European Medicines Agency, which were published following a review of data showing an increased risk of developmental disorders among children exposed to topiramate before birth.…
Pilot sites for community pharmacies to refer patients with signs of possible cancer delayed Exclusive: Pharmacy representatives from two of the the four areas that had signed up to provide the pilot service have said they are experiencing delays, while one cancer alliance has pulled out of the scheme.…
Pharmacists can do more to bridge the safety gaps for people with learning disabilities People with learning disabilities are more likely to be taking multiple medicines, but labels are not designed with them in mind — it is time to pay more attention to this patient group’s needs.…